iCureASPS Fundraising

Support Team ASPS in the 2009 Pan-Massachusetts Challenge (PMC)

This weekend, Team ASPS rode the Pan-Massachusetts Challenge (PMC) for the 6th time. This bike-a-thon crosses Massachusetts to raise money for cancer research and clinical trials at the Dana-Farber Cancer Institute in Boston. Donations raised by Team ASPS are restricted for research and clinical trials that aim to find cure for Alveolar Soft Part Sarcoma. […]

Fundraiser in the memory of Anthony Salisbury (AJ)

On 26 January 2009, we lost Anthony Salisbury (AJ) to ASPS. AJ’s fiancé, family and friends remain committed to finding a cure for ASPS. In February 2009 they organized the“Knockin’ Down ASPS” event. During this fundraiser they collected over $19,000. Of that money, $3,000 went to AJ’s family, and $16,000 were donated to the laboratory […]

Gene Expression Profiling of Alveolar Soft-Part Sarcoma (ASPS)

Dr. David Vistica, and his collaborators from the National Cancer Institute (in Frederick, MD), published the results from their analysis of gene expression in donated ASPS tumors. It identified elevated expression of genes, related to cancer. These may have diagnostic and therapeutic potential. Few examples are: Involved in angiogenesis: ANGPTL2, HIF-1 alpha, MDK, c-MET, VEGF, […]

Feedback II – The GVAX Cancer Vaccine Trial at the Dana Farber

The GVAX cancer vaccine clinical trial, which has been opened in January 2006 is no more recruiting new patients. When it was open it recruited in addition to Alveolar Soft Part Sarcoma also Clear Cell Sarcoma, Renal Cell Carcinoma and Melanoma patients. In June 2007 I shared with you an e-mail from a parent whose […]

A Press Release – ARQ197

ArQule Achieves Clinical Milestone in MiT Trial with ARQ 197 Thursday October 2, 8:01 am ET Confirmed tumor response in clear cell sarcoma leads to expanded trial WOBURN, Mass.–(BUSINESS WIRE)–ArQule, Inc. (NASDAQ: ARQL – News) today announced the expansion of its Phase 2 trial with ARQ 197, a proprietary, orally administered small molecule inhibitor of […]

Research sponsored by iCureASPS published: Is ASPS a target for Halofuginone therapy?

Cure Alveolar Soft Part Sarcoma International is very proud to announce the publication of a study that was supported by donations through our organization. The new study appears in the scientific journal ”Neoplasia”. It focuses on genes which are expressed in alveolar soft part sarcoma and in the normal cells surrounding the tumor. Those cells […]